Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM ANHYDROUS vs METARAMINOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM ANHYDROUS vs METARAMINOL: Safety Overview

Metric MEROPENEM ANHYDROUS METARAMINOL
Total FAERS Reports 144 165
Deaths Reported 25 27
Death Rate 17.4% 16.4%
Hospitalizations 102 41
Average Patient Age 55.0 yrs 56.4 yrs
% Female Patients 44.2% 55.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Mylan Institutional LLC N/A
Route INTRAVENOUS N/A
Marketing Status N/A Discontinued